These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 21047391

  • 1. Baseline severe anaemia should not preclude use of zidovudine in antiretroviral-eligible patients in resource-limited settings.
    Kiragga AN, Castelnuovo B, Nakanjako D, Manabe YC.
    J Int AIDS Soc; 2010 Nov 03; 13():42. PubMed ID: 21047391
    [Abstract] [Full Text] [Related]

  • 2. Anaemia and zidovudine-containing antiretroviral therapy in paediatric antiretroviral programmes in the IeDEA Paediatric West African Database to evaluate AIDS.
    Renner LA, Dicko F, Kouéta F, Malateste K, Gueye RD, Aka E, Eboua TK, Azondékon A, Okomo U, Touré P, Ekouévi D, Leroy V, IeDEA West Africa Paediatric Collaboration.
    J Int AIDS Soc; 2013 Sep 17; 16(1):18024. PubMed ID: 24047928
    [Abstract] [Full Text] [Related]

  • 3. Prior antiretroviral therapy experience protects against zidovudine-related anaemia.
    Huffam SE, Srasuebkul P, Zhou J, Calmy A, Saphonn V, Kaldor JM, Ditangco R, TREAT Asia HIV Observational Database (TAHOD).
    HIV Med; 2007 Oct 17; 8(7):465-71. PubMed ID: 17760739
    [Abstract] [Full Text] [Related]

  • 4. Prevalence, incidence and predictors of severe anaemia with zidovudine-containing regimens in African adults with HIV infection within the DART trial.
    Ssali F, Stöhr W, Munderi P, Reid A, Walker AS, Gibb DM, Mugyenyi P, Kityo C, Grosskurth H, Hakim J, Byakwaga H, Katabira E, Darbyshire JH, Gilks CF, DART Trial Team.
    Antivir Ther; 2006 Oct 17; 11(6):741-9. PubMed ID: 17310818
    [Abstract] [Full Text] [Related]

  • 5. High incidence of zidovudine induced anaemia in HIV infected patients in eastern India.
    Agarwal D, Chakravarty J, Chaube L, Rai M, Agrawal NR, Sundar S.
    Indian J Med Res; 2010 Oct 17; 132():386-9. PubMed ID: 20966515
    [Abstract] [Full Text] [Related]

  • 6. Evaluating the utility of early laboratory monitoring of antiretroviral-induced haematological and hepatic toxicity in HIV-infected persons in Cameroon.
    Bekolo CE, Sonkoue C, Djidjou H, Bekoule PS, Kollo B.
    BMC Infect Dis; 2014 Sep 25; 14():519. PubMed ID: 25253124
    [Abstract] [Full Text] [Related]

  • 7. Incidence of anaemia and impact on sustained virological response in HIV/HCV-coinfected patients treated with pegylated interferon plus ribavirin.
    Núñez M, Ocampo A, Aguirrebengoa K, Cervantes M, Pascual A, Echeverria S, Asensi V, Barreiro P, Garcia-Samaniego J, Soriano V, PRESCO Team.
    J Viral Hepat; 2008 May 25; 15(5):363-9. PubMed ID: 18179454
    [Abstract] [Full Text] [Related]

  • 8. Development of Severe Anemia and Changes in Hemoglobin in a Cohort of HIV-Infected Ugandan Adults Receiving Zidovudine-, Stavudine-, and Tenofovir-Containing Antiretroviral Regimens.
    Parkes-Ratanshi R, Katende D, Levin J, Wakeham K, Heiner G, Kamali A, Lalloo DG.
    J Int Assoc Provid AIDS Care; 2015 May 25; 14(5):455-62. PubMed ID: 25425638
    [Abstract] [Full Text] [Related]

  • 9. Short-term risk of anaemia following initiation of combination antiretroviral treatment in HIV-infected patients in countries in sub-Saharan Africa, Asia-Pacific, and central and South America.
    Zhou J, Jaquet A, Bissagnene E, Musick B, Wools-Kaloustian K, Maxwell N, Boulle A, Wehbe F, Masys D, Iriondo-Perez J, Hemingway-Foday J, Law M, Western Africa, Eastern Africa, Southern Africa, Caribbean and Central and South America, and Asia Pacific Regions of the International Epidemiologic Databases to Evaluate AIDS-IeDEA.
    J Int AIDS Soc; 2012 Jan 30; 15(1):5. PubMed ID: 22289654
    [Abstract] [Full Text] [Related]

  • 10. Anaemia in HIV-infected children: severity, types and effect on response to HAART.
    Nyesigire Ruhinda E, Bajunirwe F, Kiwanuka J.
    BMC Pediatr; 2012 Oct 31; 12():170. PubMed ID: 23114115
    [Abstract] [Full Text] [Related]

  • 11. Predictors of Persistent Anaemia in the First Year of Antiretroviral Therapy: A Retrospective Cohort Study from Goma, the Democratic Republic of Congo.
    Akilimali PZ, Kashala-Abotnes E, Musumari PM, Kayembe PK, Tylleskar T, Mapatano MA.
    PLoS One; 2015 Oct 31; 10(10):e0140240. PubMed ID: 26474481
    [Abstract] [Full Text] [Related]

  • 12. A prospective study of haematological changes after switching from stavudine to zidovudine-based antiretroviral treatment in HIV-infected children.
    Singh A, Hemal A, Agarwal S, Dubey NK, Buxi G.
    Int J STD AIDS; 2016 Nov 31; 27(13):1145-1152. PubMed ID: 24516076
    [Abstract] [Full Text] [Related]

  • 13. Zidovudine use but not weight-based ribavirin dosing impacts anaemia during HCV treatment in HIV-infected persons.
    Alvarez D, Dieterich DT, Brau N, Moorehead L, Ball L, Sulkowski MS.
    J Viral Hepat; 2006 Oct 31; 13(10):683-9. PubMed ID: 16970600
    [Abstract] [Full Text] [Related]

  • 14. Anemia among HIV Infected Individuals Taking ART with and without Zidovudine at Addis Ababa, Ethiopia.
    Tamir Z, Alemu J, Tsegaye A.
    Ethiop J Health Sci; 2018 Jan 31; 28(1):73-82. PubMed ID: 29622909
    [Abstract] [Full Text] [Related]

  • 15. Incidence of anaemia among HIV-infected patients treated with highly active antiretroviral therapy.
    Curkendall SM, Richardson JT, Emons MF, Fisher AE, Everhard F.
    HIV Med; 2007 Nov 31; 8(8):483-90. PubMed ID: 17944680
    [Abstract] [Full Text] [Related]

  • 16. Anaemia in pregnancy is associated with advanced HIV disease.
    Nandlal V, Moodley D, Grobler A, Bagratee J, Maharaj NR, Richardson P.
    PLoS One; 2014 Nov 31; 9(9):e106103. PubMed ID: 25222119
    [Abstract] [Full Text] [Related]

  • 17. Resolution of anaemia in a cohort of HIV-infected patients with a high prevalence and incidence of tuberculosis receiving antiretroviral therapy in South Africa.
    Kerkhoff AD, Wood R, Cobelens FG, Gupta-Wright A, Bekker LG, Lawn SD.
    BMC Infect Dis; 2014 Dec 21; 14():3860. PubMed ID: 25528467
    [Abstract] [Full Text] [Related]

  • 18. Haemoglobin recovery among HIV-1 infected patients on zidovudine-based antiretroviral therapy and other regimens in north-central Nigeria.
    Parrish DD, Blevins M, Megazzini KM, Shepherd BE, Mohammed MY, Wester CW, Vermund SH, Aliyu MH.
    Int J STD AIDS; 2014 Apr 21; 25(5):355-9. PubMed ID: 24104694
    [Abstract] [Full Text] [Related]

  • 19. Haematological changes in adults receiving a zidovudine-containing HAART regimen in combination with cotrimoxazole in Côte d'Ivoire.
    Moh R, Danel C, Sorho S, Sauvageot D, Anzian A, Minga A, Gomis OB, Konga C, Inwoley A, Gabillard D, Bissagnene E, Salamon R, Anglaret X.
    Antivir Ther; 2005 Apr 21; 10(5):615-24. PubMed ID: 16152755
    [Abstract] [Full Text] [Related]

  • 20. Risk factors of treatment-limiting anemia after substitution of zidovudine for stavudine in HIV-infected adult patients on antiretroviral treatment.
    Phe T, Thai S, Veng C, Sok S, Lynen L, van Griensven J.
    PLoS One; 2013 Apr 21; 8(3):e60206. PubMed ID: 23555926
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.